infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 10 of 208 articles from: Harm reduction interventions and policy

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • UK: Impact on hepatitis C means needle exchanges save lives and can reduce costs

    Drug & Alcohol Findings / 11 March 2019

  • Overdue for a Change: Scaling Up Supervised Consumption Services in Canada

    Canadian HIV/AIDS Legal Network / 19 February 2019

  • Safe consumption sites: Study identifies policy change strategies and challenges

    Manual Items / 15 February 2019

  • Safe Injection Site for Opioid Users Faces Trump Administration Crackdown

    New York Times / 07 February 2019

  • Needle and syringe programs cost-effectively prevent hepatitis C transmission

    Eurekalert Medicine & Health / 29 January 2019

  • Bulgarian Harm Reduction Drown in Bureaucracy: Interview with Yuliya Georgieva

    Drug Reporter / 07 December 2018

  • 8 Lessons Learned at the European Harm Reduction Conference

    Drug Reporter / 04 December 2018

  • This City’s Overdose Deaths Have Plunged. Can Others Learn From It?

    New York Times / 26 November 2018

  • Naloxone rescue kits empowering peers of drug users to ‘save lives’ in Scotland

    Drug & Alcohol Findings / 23 November 2018

  • How 'fixing rooms' are saving the lives of drug addicts

    The Guardian / 22 November 2018

← Prev12345...21Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2022. All rights reserved. We are not responsible for the content of external websites.

Company limited by guarantee. Registered in England & Wales, number: 2707596. Registered charity, number: 1011220

Infohep has been supported by a grant from Gilead Sciences Europe Ltd. Our funder has had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

infohep is produced by NAM. Find out more about NAM

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//